A carregar...

Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion

Introduction: Denosumab, a fully human monoclonal antibody, targets the receptor activator of nuclear factor-kappaB (RANK) ligand, a protein essential for osteoclast differentiation, activity and survival. Loss of osteoclasts from the bone surface reduces bone turnover and bone loss in malignant and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Steger, Guenther G., Bartsch, Rupert
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3169928/
https://ncbi.nlm.nih.gov/pubmed/21957430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834011412656
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!